EGFR and non-small cell lung carcinoma: A previous retrospective study3 reported significantly improved PFS among patients with EGFR-mutated stage III NSCLC who were given induction or consolidative EGFR TKI in conjunction with CRT compared with the PACIFIC regimen (26.1 months vs 10.3 months).